Paradigm Asset Management Co Has Increased Gilead Sciences (GILD) Position By $479.98 Million; Kulicke & Soffa Industries (KLIC) Sentiment Is 0.88

April 20, 2018 - By Marguerite Chambers

Gilead Sciences, Inc. (NASDAQ:GILD) Logo

Kulicke & Soffa Industries Inc (KLIC) investors sentiment decreased to 0.88 in 2017 Q4. It’s down -0.15, from 1.03 in 2017Q3. The ratio turned negative, as 84 investment managers increased and started new positions, while 96 sold and reduced their stakes in Kulicke & Soffa Industries Inc. The investment managers in our database now have: 58.53 million shares, down from 59.03 million shares in 2017Q3. Also, the number of investment managers holding Kulicke & Soffa Industries Inc in top ten positions increased from 2 to 3 for an increase of 1. Sold All: 14 Reduced: 82 Increased: 54 New Position: 30.

Paradigm Asset Management Co Llc increased Gilead Sciences Inc. (GILD) stake by 18.25% reported in 2017Q4 SEC filing. Paradigm Asset Management Co Llc acquired 6,700 shares as Gilead Sciences Inc. (GILD)’s stock rose 1.93%. The Paradigm Asset Management Co Llc holds 43,410 shares with $3.11B value, up from 36,710 last quarter. Gilead Sciences Inc. now has $95.74 billion valuation. The stock decreased 1.36% or $1.01 during the last trading session, reaching $73.43. About 2.91M shares traded. Gilead Sciences, Inc. (NASDAQ:GILD) has risen 9.79% since April 20, 2017 and is uptrending. It has underperformed by 1.76% the S&P500.

Among 30 analysts covering Gilead Sciences (NASDAQ:GILD), 21 have Buy rating, 0 Sell and 9 Hold. Therefore 70% are positive. Gilead Sciences had 126 analyst reports since July 29, 2015 according to SRatingsIntel. Cowen & Co maintained Gilead Sciences, Inc. (NASDAQ:GILD) on Monday, September 21 with “Buy” rating. The rating was upgraded by Wells Fargo to “Outperform” on Tuesday, January 16. William Blair maintained Gilead Sciences, Inc. (NASDAQ:GILD) on Wednesday, June 14 with “Buy” rating. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) earned “Outperform” rating by Oppenheimer on Thursday, February 11. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) earned “Hold” rating by Leerink Swann on Thursday, February 22. On Wednesday, July 29 the stock rating was maintained by Oppenheimer with “Outperform”. The rating was maintained by BMO Capital Markets with “Hold” on Monday, August 28. The firm earned “Outperform” rating on Wednesday, November 2 by RBC Capital Markets. Credit Suisse maintained it with “Buy” rating and $79.0 target in Monday, August 28 report. The firm has “Buy” rating by Berenberg given on Thursday, September 22.

Investors sentiment decreased to 0.8 in 2017 Q4. Its down 0.23, from 1.03 in 2017Q3. It dropped, as 95 investors sold GILD shares while 545 reduced holdings. 104 funds opened positions while 411 raised stakes. 972.68 million shares or 1.57% more from 957.62 million shares in 2017Q3 were reported. Sterling Cap Ltd Llc invested 0.78% in Gilead Sciences, Inc. (NASDAQ:GILD). Moreover, Diligent Ltd Com has 0.14% invested in Gilead Sciences, Inc. (NASDAQ:GILD). Nelson Van Denburg Campbell Wealth Grp Ltd Liability Corporation invested in 7,634 shares. Utd Capital Fincl Advisers Lc holds 0.21% or 363,252 shares in its portfolio. Qci Asset Management Ny holds 0% or 656 shares in its portfolio. Bradley Foster Sargent Ct invested in 0.15% or 57,328 shares. Riverpoint Cap Mngmt Ltd invested in 3,615 shares or 0.02% of the stock. Old Natl Natl Bank In owns 29,470 shares. Oakworth has invested 0.13% in Gilead Sciences, Inc. (NASDAQ:GILD). Moreover, Capital Rech has 0.68% invested in Gilead Sciences, Inc. (NASDAQ:GILD) for 32.32 million shares. State Of Alaska Department Of Revenue holds 128,498 shares. 90,428 are held by Lowe Brockenbrough & Com. Cetera Advisor Ltd Liability Company owns 0.1% invested in Gilead Sciences, Inc. (NASDAQ:GILD) for 32,847 shares. First Midwest Bancorporation Tru Division owns 42,417 shares or 0.38% of their US portfolio. 7,778 were accumulated by Bridges Investment Counsel Incorporated.

Since January 2, 2018, it had 0 insider purchases, and 17 insider sales for $39.51 million activity. 5,833 Gilead Sciences, Inc. (NASDAQ:GILD) shares with value of $437,588 were sold by Cogan John Francis. $2.37M worth of stock was sold by Alton Gregg H on Thursday, January 11. Washington Robin L also sold $401,566 worth of Gilead Sciences, Inc. (NASDAQ:GILD) on Wednesday, February 21. 50,000 shares valued at $3.68M were sold by MARTIN JOHN C on Tuesday, January 2. Meyers James R sold 100,000 shares worth $8.02 million. Another trade for 60,000 shares valued at $4.68M was sold by WILSON GAYLE E.

Paradigm Asset Management Co Llc decreased Regions Financial Corp (NYSE:RF) stake by 53,200 shares to 179,910 valued at $3.11B in 2017Q4. It also reduced Zoetis Inc (NYSE:ZTS) stake by 8,300 shares and now owns 37,580 shares. Ollie’s Bargain Outlet Hd was reduced too.

Since January 1, 0001, it had 0 insider buys, and 3 selling transactions for $27,540 activity.

Kulicke and Soffa Industries, Inc. designs, makes, and sells capital equipment and expendable tools to assemble semiconductor devices. The company has market cap of $1.73 billion. It operates in two divisions, Equipment and Expendable Tools. It has a 65.66 P/E ratio. The Equipment segment makes and sells a line of ball bonders to connect very fine wires made of gold, silver alloy, or copper between the bond pads of the semiconductor devices or dies, and the leads on its package; wafer level bonders, which mechanically applies bumps to dies for some variants of the flip chip assembly process; and wedge bonders to connect semiconductor chips for the power packages, power hybrids, and automotive modules.

Whale Rock Capital Management Llc holds 3.77% of its portfolio in Kulicke and Soffa Industries, Inc. for 3.35 million shares. Penbrook Management Llc owns 137,100 shares or 3% of their US portfolio. Moreover, Copper Rock Capital Partners Llc has 2.34% invested in the company for 1.56 million shares. The California-based Sensato Investors Llc has invested 1.95% in the stock. Eii Capital Management Inc., a New York-based fund reported 91,818 shares.

The stock increased 0.82% or $0.2 during the last trading session, reaching $24.49. About 377,493 shares traded. Kulicke and Soffa Industries, Inc. (KLIC) has risen 21.63% since April 20, 2017 and is uptrending. It has outperformed by 10.08% the S&P500.

Analysts await Kulicke and Soffa Industries, Inc. (NASDAQ:KLIC) to report earnings on May, 2. They expect $0.41 earnings per share, up 2.50% or $0.01 from last year’s $0.4 per share. KLIC’s profit will be $28.95M for 14.93 P/E if the $0.41 EPS becomes a reality. After $0.51 actual earnings per share reported by Kulicke and Soffa Industries, Inc. for the previous quarter, Wall Street now forecasts -19.61% negative EPS growth.

Kulicke and Soffa Industries, Inc. (NASDAQ:KLIC) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts